PARP inhibitors interfere with cancer’s ability to repair damage to its DNA. They are becoming increasingly useful in treating ovarian cancer.
Arelene Weintraub
Advertisement
Articles by Arelene Weintraub
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
FDA Grants Final Approval to OMCAZIO, a New Capsule Formulation of Cabozantinib
4
Why Patients With the Same Cancer Respond Differently to Treatment
5